OTCMKTS:NPHC - Nutra Pharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0003 0.00 (0.00 %)
(As of 04/25/2019 04:39 AM ET)
Previous Close$0.0003
Today's Range$0.0002 - $0.0003
52-Week Range$0.0001 - $0.0023
Volume1.23 million shs
Average Volume6.73 million shs
Market Capitalization$599,998.80
P/E RatioN/A
Dividend YieldN/A
Nutra Pharma Corp. is a biopharmaceutical company, which is engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies & homeopathic and ethical drugs for the management of pain, neurological disorders, autoimmune and infectious diseases. Its products are Cobroxin, which is used for an over-the-counter pain reliever designed to treat moderate to severe chronic pain and Nyloxin Extra Strength, which is used for stronger versions of Cobroxin. The company was founded on February 1, 2000 and is headquartered in Coral Springs, FL.

Receive NPHC News and Ratings via Email

Sign-up to receive the latest news and ratings for NPHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medicinals & botanicals
Current SymbolOTCMKTS:NPHC



Sales & Book Value

Annual Sales$120,000.00


Net Income$-4,020,000.00
Net Margins-4,741.67%


Outstanding Shares1,999,996,000
Market Cap$599,998.80
Next Earnings Date5/20/2019 (Estimated)
OptionableNot Optionable

Nutra Pharma (OTCMKTS:NPHC) Frequently Asked Questions

What is Nutra Pharma's stock symbol?

Nutra Pharma trades on the OTCMKTS under the ticker symbol "NPHC."

How were Nutra Pharma's earnings last quarter?

Nutra Pharma Corp. (OTCMKTS:NPHC) issued its quarterly earnings results on Friday, August, 17th. The company reported $0.00 earnings per share (EPS) for the quarter. The business had revenue of $0.03 million for the quarter. View Nutra Pharma's Earnings History.

When is Nutra Pharma's next earnings date?

Nutra Pharma is scheduled to release their next quarterly earnings announcement on Monday, May 20th 2019. View Earnings Estimates for Nutra Pharma.

Has Nutra Pharma been receiving favorable news coverage?

Media stories about NPHC stock have trended somewhat negative recently, according to InfoTrie. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Nutra Pharma earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days.

Who are some of Nutra Pharma's key competitors?

What other stocks do shareholders of Nutra Pharma own?

Who are Nutra Pharma's key executives?

Nutra Pharma's management team includes the folowing people:
  • Rik J. Deitsch, Chairman, President, CEO, CFO & CAO
  • Dale Vanderputten, Chief Scientific Officer
  • Nina Goldstein, Marketing Director & Media Relations Contact

How do I buy shares of Nutra Pharma?

Shares of NPHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nutra Pharma's stock price today?

One share of NPHC stock can currently be purchased for approximately $0.0003.

How big of a company is Nutra Pharma?

Nutra Pharma has a market capitalization of $599,998.80 and generates $120,000.00 in revenue each year. Nutra Pharma employs 4 workers across the globe.

What is Nutra Pharma's official website?

The official website for Nutra Pharma is http://www.nutrapharma.com.

How can I contact Nutra Pharma?

Nutra Pharma's mailing address is 12538 WEST ATLANTIC BLVD., CORAL SPRINGS FL, 33071. The company can be reached via phone at 954-509-0911 or via email at [email protected]

MarketBeat Community Rating for Nutra Pharma (OTCMKTS NPHC)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  62 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  108
MarketBeat's community ratings are surveys of what our community members think about Nutra Pharma and other stocks. Vote "Outperform" if you believe NPHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NPHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/25/2019 by MarketBeat.com Staff

Featured Article: Outstanding Shares

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel